GlassScriptPhysician profile
Jane M Joseph
NPI 1952840936
$1,402.88
in general payments reported to CMS, 2019-2025
15 companies · $607 in 2025
The $607 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $200 · 2023: $313 · 2024: $282 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.43 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.64 | 2023-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $132.85 | 2025 | Amvuttra |
| Pfizer INC. | $126.77 | 2025 | |
| Janssen Pharmaceuticals, INC | $117.98 | 2022-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $80.11 | 2022-2024 | Farxiga |
| Kestra Medical Technology Services, INC. | $74.57 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $73.13 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $57.89 | 2023-2024 | |
| Chiesi USA, INC. | $55.23 | 2024-2025 | Kengreal |
| Abbott Laboratories | $44.88 | 2023-2025 | Cardiomems, Mitraclip |
| Abiomed | $35.07 | 2025 | |
| Bridgebio Pharma, INC. | $27.01 | 2025 | Attruby |
| Medtronic, INC. | $22.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.